Literature DB >> 10633602

Hemodialysis patients' noncompliance with oral medications.

R B Curtin1, B L Svarstad, T H Keller.   

Abstract

The purpose of this study was to describe the prevalence, severity, and patterns of noncompliance with prescribed medications among hemodialysis patients; and to identify patient, disease and/or treatment characteristics associated with noncompliance. Demographic and medical history information were collected from chart reviews and patient interviews. Compliance data were collected via self-report, pill count, and a medication event monitoring system (MEMS, Product of Aprex, a division of Apria Healthcare; Costa Mesa, CA). A total of 135 hemodialysis patients from 11 dialysis facilities in a large Midwestern metropolitan area participated. Overall, medication compliance rates were very low. Of the patient, disease, and treatment characteristics considered, only race was found to be associated with patient noncompliance; African-American patients had higher rates of noncompliance with both monitored medications. The results of this study confirm that noncompliance with medication regimens continues to be an unremitting problem for hemodialysis patients and that demographic, medical history, and treatment characteristics do not adequately explain this behavior. Also, estimates of patient compliance as measured by self-report, pill count, and microelectronic monitoring are disparate enough to suggest that relying exclusively on patients' self-report of compliance might be insufficient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10633602

Source DB:  PubMed          Journal:  ANNA J        ISSN: 8750-0779


  24 in total

1.  Racial/ethnic differences in the use of psychotropic medication in high-risk children and adolescents.

Authors:  Laurel K Leslie; Jill Weckerly; John Landsverk; Richard L Hough; Michael S Hurlburt; Patricia A Wood
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-12       Impact factor: 8.829

Review 2.  Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices.

Authors:  Lizheng Shi; Jinan Liu; Yordanka Koleva; Vivian Fonseca; Anupama Kalsekar; Manjiri Pawaskar
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  Medication adherence assessment in a clinical trial with centralized follow-up and direct-to-patient drug shipments.

Authors:  Stuart R Warren; Dennis W Raisch; Heather M Campbell; Peter D Guarino; James S Kaufman; Elizabeth Petrokaitis; David S Goldfarb; J Michael Gaziano; Rex L Jamison
Journal:  Clin Trials       Date:  2011-08-03       Impact factor: 2.486

4.  Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS.

Authors:  Rachel B Fissell; Angelo Karaboyas; Brian A Bieber; Ananda Sen; Yun Li; Antonio A Lopes; Takashi Akiba; Jürgen Bommer; Jean Ethier; Michel Jadoul; Ronald L Pisoni; Bruce M Robinson; Francesca Tentori
Journal:  Hemodial Int       Date:  2015-05-14       Impact factor: 1.812

5.  Impact of race on cumulative exposure to antihypertensive medications in dialysis.

Authors:  James B Wetmore; Jonathan D Mahnken; Sally K Rigler; Edward F Ellerbeck; Purna Mukhopadhyay; Qingjiang Hou; Theresa I Shireman
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

6.  Association of race with cumulative exposure to statins in dialysis.

Authors:  James B Wetmore; Jonathan D Mahnken; Sally K Rigler; Edward F Ellerbeck; Purna Mukhopadhyay; Qingjiang Hou; Theresa I Shireman
Journal:  Am J Nephrol       Date:  2012-06-27       Impact factor: 3.754

Review 7.  A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence.

Authors:  Mohamed El Alili; Bernard Vrijens; Jenny Demonceau; Silvia M Evers; Mickael Hiligsmann
Journal:  Br J Clin Pharmacol       Date:  2016-05-02       Impact factor: 4.335

8.  The Quantitative Analgesic Questionnaire: A Tool to Capture Patient-Reported Chronic Pain Medication Use.

Authors:  Jessica Robinson-Papp; Mary Catherine George; Arada Wongmek; Alexandra Nmashie; Jessica S Merlin; Yousaf Ali; Lawrence Epstein; Mark Green; Stelian Serban; Parag Sheth; David M Simpson
Journal:  J Pain Symptom Manage       Date:  2015-04-23       Impact factor: 3.612

9.  Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.

Authors:  Sunil V Badve; Deborah L Zimmerman; Greg A Knoll; Kevin D Burns; Brendan B McCormick
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

Review 10.  Depression in African-American patients with kidney disease.

Authors:  Paul L Kimmel; Somir S Patel; Rolf A Peterson
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.